Anika Therapeutics

Yahoo Finance • 5 days ago

Telix Strengthens Board with Additional Director Appointments

MELBOURNE, Australia and INDIANAPOLIS, April 09, 2026 (GLOBE NEWSWIRE) -- Telix Pharmaceuticals Limited (ASX: TLX, NASDAQ: TLX, “Telix”) today announces two additional Non-Executive Director (NED) appointments, effective May 11, 20261, a... Full story

Yahoo Finance • 6 days ago

Revance CEO Nadeem Moiz on Expansion, Opportunities & Capitalization

By Karen Roman Exec Edge sat down with Nadeem Moiz, Chief Executive Officer at Revance, to learn more about the company’s vision in aesthetics, skincare and therapeutics. Exec Edge: Tell us about Revance and the science-powered products... Full story

Yahoo Finance • 10 days ago

Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)

BEDFORD, Mass., April 03, 2026 (GLOBE NEWSWIRE) -- Anika Therapeutics, Inc. (NASDAQ: ANIK), a global leader in the osteoarthritis pain management and regenerative solutions spaces focused on early intervention orthopedics, today announce... Full story

Yahoo Finance • 2 months ago

Anika Therapeutics Q4 Earnings Call Highlights

Anika Therapeutics logo Anika Therapeutics (NASDAQ:ANIK) detailed its fourth-quarter and full-year 2025 results and outlined its strategy for 2026 during its earnings call on Thursday, highlighting commercial-channel growth, progress on i... Full story

Yahoo Finance • 2 months ago

Here are the major earnings before the open Thursday

Major earnings expected before the bell on Thursday include: * Viatris (VTRS [https://seekingalpha.com/symbol/VTRS]) * Baidu (BIDU [https://seekingalpha.com/symbol/BIDU]) * Vistance Networks (VISN [https://seekingalpha.com/symbol/VI... Full story

Yahoo Finance • 4 months ago

Anika Therapeutics, Inc. INVESTIGATION: Kirby McInerney LLP Announces Investigation Into Potential Securities Fraud on behalf of Investors ANIK

NEW YORK, Dec. 05, 2025 (GLOBE NEWSWIRE) -- The law firm of Kirby McInerney LLP is investigating potential claims against Anika Therapeutics, Inc. (“Anika” or the “Company”) (NASDAQ:ANIK). The investigation concerns whether the Company a... Full story

Yahoo Finance • 5 months ago

Anika (ANIK) Q3 2025 Earnings Call Transcript

Image source: The Motley Fool. DATE Wednesday, Nov. 5, 2025 at 8:30 a.m. ET CALL PARTICIPANTS President and Chief Executive Officer — Dr. Cheryl Renee Blanchard Executive Vice President, Chief Financial Officer, and Chief Operating Of... Full story

Yahoo Finance • 5 months ago

Anika Reports Third Quarter 2025 Financial Results

Commercial Channel revenue up 22% with continued strong Integrity™ Implant System and Hyalofast® growth, and double-digit International OA Pain Management growth Third and final Hyalofast PMA module filed and data released Cingal® achiev... Full story

Yahoo Finance • 6 months ago

ANIKA INVESTIGATION REMINDER: Bragar Eagel & Squire, P.C. Reminds Anika Therapeutics Investors to Contact the Firm Regarding the Ongoing Investigation on Behalf of Anika Stockholders

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Anika (ANIK) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Anika and would like to discuss... Full story

Yahoo Finance • 6 months ago

Notable Friday Option Activity: SIRI, BTBT, FCX

Among the underlying components of the Russell 3000 index, we saw noteworthy options trading volume today in SiriusXM Holdings Inc (Symbol: SIRI), where a total of 13,945 contracts have traded so far, representing approximately 1.4 million... Full story

Yahoo Finance • 7 months ago

ANIKA (ANIK) ALERT: Bragar Eagel & Squire, P.C. is Investigating Anika Therapeutics, Inc. on Behalf of Anika Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Anika (ANIK) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Anika and would like to discuss... Full story

Yahoo Finance • 7 months ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK

NEW YORK, Sept. 10, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Anika Therapeutics, Inc. (“Anika” or the “Company”) (NASDAQ: ANIK).  Such investors are advised to contact Danielle Peyton at n... Full story

Yahoo Finance • 8 months ago

CVB Financial (CVBF) Passes Through 4% Yield Mark

Looking at the universe of stocks we cover at Dividend Channel, in trading on Monday, shares of CVB Financial Corp (Symbol: CVBF) were yielding above the 4% mark based on its quarterly dividend (annualized to $0.8), with the stock changing... Full story

Yahoo Finance • 8 months ago

ANIKA ALERT: Bragar Eagel & Squire, P.C. is Investigating Anika Therapeutics, Inc. on Behalf of Anika Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Anika (ANIK) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Anika and would like to discuss... Full story

Yahoo Finance • 8 months ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Anika Therapeutics, Inc. - ANIK

NEW YORK, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of Anika Therapeutics, Inc. (“Anika” or the “Company”) (NASDAQ: ANIK).  Such investors are advised to contact Danielle Peyton at new... Full story

Yahoo Finance • 8 months ago

Bragar Eagel & Squire, P.C. Is Investigating Nutex, Anika, Fluor, and Inspire Medical and Encourages Investors to Contact the Firm

NEW YORK, Aug. 20, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against Nutex Health Inc. (NASDAQ:NUTX), Anika Therapeutics, Inc. (NASDAQ:ANI... Full story

Yahoo Finance • 8 months ago

ANIKA (ANIK) ALERT: Bragar Eagel & Squire, P.C. Continues Investigating Anika Therapeutics, Inc. on Behalf of Anika Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Anika (ANIK) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Anika and would like to discuss... Full story

Yahoo Finance • 8 months ago

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims on Behalf of Investors of Anika Therapeutics, Inc. - ANIK

NEW YORK, Aug. 09, 2025 (GLOBE NEWSWIRE) -- Pomerantz LLP is investigating claims on behalf of investors of  Anika Therapeutics, Inc. (“Anika” or the “Company”) (NASDAQ: ANIK).  Such investors are advised to contact Danielle Peyton at ne... Full story

Yahoo Finance • 8 months ago

ANIKA INVESTIGATION ALERT: Bragar Eagel & Squire, P.C. is Investigating Anika Therapeutics, Inc. on Behalf of Anika Stockholders and Encourages Investors to Contact the Firm

Bragar Eagel & Squire, P.C. Litigation Partner Brandon Walker Encourages Investors Who Suffered Losses In Anika (ANIK) To Contact Him Directly To Discuss Their Options If you purchased or acquired stock in Anika and would like to discuss... Full story

Yahoo Finance • 8 months ago

ANIKA THERAPEUTICS INC (NASDAQ:ANIK) Reports Mixed Q2 2025 Results with Revenue Beat but EPS Miss, Shares Drop 9% in Pre-Market

ANIKA THERAPEUTICS INC (NASDAQ:ANIK [https://www.chartmill.com/stock/quote/ANIK/profile]) reported mixed second-quarter 2025 financial results, with revenue exceeding expectations but earnings per share (EPS) falling short of analyst estim... Full story